Cargando…
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
PURPOSE: The aim of the present study based on the PriCoTTF‐phase I/II trial is the quantification of skin‐normal tissue complication probabilities of patients with newly diagnosed glioblastoma multiforme treated with Tumor Treating Field (TTField) electrodes, concurrent radiotherapy, and temozolomi...
Autores principales: | Nour, Youness, Pöttgen, Christoph, Kebir, Sied, Lazaridis, Lazaros, Lüdemann, Lutz, Guberina, Maja, Gauler, Thomas, Scheffler, Björn, Jabbarli, Ramazan, Pierscianek, Daniela, Sure, Ulrich, Schmidt, Teresa, Oster, Christoph, Hau, Peter, Glas, Martin, Lübcke, Wolfgang, Stuschke, Martin, Guberina, Nika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856507/ https://www.ncbi.nlm.nih.gov/pubmed/33389825 http://dx.doi.org/10.1002/acm2.13144 |
Ejemplares similares
-
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
por: Guberina, N., et al.
Publicado: (2020) -
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis
por: Guberina, Nika, et al.
Publicado: (2023) -
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022
por: Oster, Christoph, et al.
Publicado: (2023) -
How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis
por: Jabbarli, Ramazan, et al.
Publicado: (2021) -
Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice
por: Guberina, M., et al.
Publicado: (2023)